
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type |
Project #![]() |
RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2018 | R33 | CA225539 | RFA-CA-17-011 | JIANG, NING | UNIVERSITY OF TEXAS, AUSTIN | An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer | Active |
2018 | R21 | CA217735 | RFA-CA-17-010 | ENGLER, ADAM JEFFREY | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells | Complete |
2018 | R33 | CA225863 | RFA-CA-17-011 | LU, JUN | YALE UNIVERSITY | CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer | NCE |
2018 | R33 | CA223581 | RFA-CA-17-011 | CHENG, JI-XIN | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) | Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level | Active |
2018 | R21 | CA228948 | RFA-CA-17-010 | SCHIBEL, ANNA | ELECTRONIC BIOSCIENCES, INC. | Microsatellite Sequencing to Enable Cancer Genotyping | NCE |
2018 | R33 | CA228979 | RFA-CA-17-011 | SCHRUM, ADAM G | UNIVERSITY OF MISSOURI-COLUMBIA | Multiplex matrix ELISA for T cell protein-interaction networks in cancer | Active |
2018 | R33 | CA217702 | RFA-CA-17-013 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity | Active |
2018 | R21 | CA228997 | RFA-CA-17-010 | ROYZEN, MAKSIM | STATE UNIVERSITY OF NEW YORK AT ALBANY | Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies | Active |
2018 | R33 | CA229023 | RFA-CA-17-011 | TEWARI, MUNEESH (contact); WALTER, NILS G | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations | Active |
2018 | R33 | CA223947 | RFA-CA-17-011 | BROWN, BRIAN D | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Pro-Codes: A novel vector and cell barcoding technology | Active |
2018 | R21 | CA229027 | RFA-CA-17-012 | SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES | Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids | Complete |
2018 | R21 | CA229037 | RFA-CA-17-012 | GULLEY, MARGARET L | UNIV OF NORTH CAROLINA CHAPEL HILL | EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing | Active |
2018 | R21 | CA229044 | RFA-CA-17-010 | ABBOTT, KAREN L | UNIV OF ARKANSAS FOR MED SCIS | Novel platform linking cancer-specific glycosylation with cell signaling outcomes | Active |
2018 | R21 | CA229057 | RFA-CA-17-010 | FU, XIAO-AN | UNIVERSITY OF LOUISVILLE | A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath | Active |
2018 | R21 | CA214285 | RFA-CA-17-010 | MAILLOUX, ADAM WILLIAM | H. LEE MOFFITT CANCER CTR & RES INST | Autohistomagnetic Isolation of Tumor-reactive T-cells | Complete |
2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
2020 | R33 | CA236681 | RFA-CA-19-020 | WEI, CHIA-LIN | JACKSON LABORATORY | Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer | Active |
2020 | R33 | CA236670 | RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH | Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2020 | R33 | CA240181 | RFA-CA-19-020 | COOKS, ROBERT GRAHAM | PURDUE UNIVERSITY | Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
2019 | R21 | CA223727 | RFA-CA-18-002 | HUANG, XIAOHUA | UNIVERSITY OF CALIFORNIA, SAN DIEGO | Technology for measuring telomere length of individual chromosomes of single cancer cells | NCE |
2019 | R33 | CA235254 | RFA-CA-18-003 | FIOLKA, RETO PAUL | UT SOUTHWESTERN MEDICAL CENTER | Multiscale microscope for 3D cancer imaging in model organisms and organoids | Active |
2019 | R21 | CA235285 | RFA-CA-18-002 | KENTSIS, ALEX | SLOAN-KETTERING INST CAN RESEARCH | Multi-dimensional targeted mass spectrometry technology for pathway-scale functional proteomics | Active |
2019 | R33 | CA225549 | RFA-CA-18-003 | TAVANA, HOSSEIN | UNIVERSITY OF AKRON | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery | Active |
2019 | R21 | CA235303 | RFA-CA-18-002 | YAMAMOTO, KEITH ROBERT | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | CasCUT&RUN: An in vivo method to analyze locus-specific protein complexes driving transcription of target genes in cancer | Active |
2019 | R21 | CA235305 | RFA-CA-18-002 | WU, YUN | STATE UNIVERSITY OF NEW YORK AT BUFFALO | Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection | Active |
2019 | R33 | CA235326 | RFA-CA-18-005 | LEI, YUGUO | UNIVERSITY OF NEBRASKA LINCOLN | A Single Conical Tube Device for Precision CAR-T Cells Manufacturing | Active |
2019 | R21 | CA235340 | RFA-CA-18-002 | ZHU, YAZHEN | UNIVERSITY OF CALIFORNIA LOS ANGELES | Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs | Active |
2019 | R43 | CA236103 | PAR-18-303 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC. | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | Complete |
2018 | R43 | CA236101 | PAR-18-303 | LEE, LY JAMES | NANOMATERIAL INNOVATION, LTD | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis | Complete |
2019 | R43 | CA236177 | PAR-18-303 | KASOJI, SANDEEP | TRIANGLE BIOTECHNOLOGY, INC. | SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | Complete |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
2018 | R43 | CA236142 | PAR-18-303 | SCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC. | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes | Complete |
2019 | R21 | CA236561 | RFA-CA-18-002 | WEISSLEDER, RALPH | MASSACHUSETTS GENERAL HOSPITAL | Single Circulating Vesicle Analysis for Early Cancer Detection | Active |
2019 | R21 | CA236594 | RFA-CA-18-002 | GARBER, MANUEL | UNIV OF MASSACHUSETTS MED SCH WORCESTER | A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells | Active |
2019 | R33 | CA229042 | RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells | Active |
2019 | R33 | CA225458 | RFA-CA-18-003 | KETTENBACH, ARMINJA NADINE | DARTMOUTH COLLEGE | Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics | Active |
2019 | R21 | CA236640 | RFA-CA-18-002 | BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories for targeting interstitial fluid pressure | Active |
2019 | R33 | CA225498 | RFA-CA-18-003 | CHEN, SIDI | YALE UNIVERSITY | Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers | Active |
2019 | R21 | CA236652 | RFA-CA-18-004 | SINGAMANENI, SRIKANTH | WASHINGTON UNIVERSITY | METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION | Active |
2019 | R21 | CA229069 | RFA-CA-18-002 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants | Active |
2019 | R21 | CA236685 | RFA-CA-18-002 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Building microenvironment-containing organoids from patient samples with single-cell precision | Active |
2019 | R33 | CA236687 | RFA-CA-18-003 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER | GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models | Active |
2019 | R21 | CA236690 | RFA-CA-18-002 | KIM, HYUN JUNG | UNIVERSITY OF TEXAS, AUSTIN | A personalized colorectal cancer-on-a-chip for assessing tumor-microbiome crosstalk | Active |
2019 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations | NCE |
2019 | R43 | CA239967 | PAR-18-303 | BROWN, MARK T | CLAREMONT BIOSOLUTIONS, LLC | Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis | Complete |